PeerVoice Immunology & Infectious Disease Video

40 Episodes
Subscribe

By: PeerVoice

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Anna Maria Geretti, MD, PhD - Understanding an Individual’s Readiness for Long-Acting Injectable Therapy
07/07/2025

Anna Maria Geretti, MD, PhD - Understanding an Individual’s Readiness for Long-Acting Injectable Therapy


Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context
05/16/2025

Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context


Nicholas J. Silvestri, MD, FAAN - From Established to Emerging Therapies: Expert Perspectives on the Latest Evidence Base on FcRn Inhibitors for gMG
04/25/2025

Nicholas J. Silvestri, MD, FAAN - From Established to Emerging Therapies: Expert Perspectives on the Latest Evidence Base on FcRn Inhibitors for gMG


Enrico Lopriore, MD, PhD - Are You Managing Pregnant Individuals? Then You Need to Know About Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT)
03/26/2025

Enrico Lopriore, MD, PhD - Are You Managing Pregnant Individuals? Then You Need to Know About Fetal-Neonatal Alloimmune Thrombocytopenia (FNAIT)


James F. Howard Jr, MD - Beyond FcRn and Complement Inhibitors: Why We Need Novel Treatment Options for Generalized Myasthenia Gravis
03/26/2025

James F. Howard Jr, MD - Beyond FcRn and Complement Inhibitors: Why We Need Novel Treatment Options for Generalized Myasthenia Gravis


Mariana Castells, MD, PhD - Rare But Highly Significant: Best Practices in Recognizing and Diagnosing Systemic Mastocytosis
01/09/2025

Mariana Castells, MD, PhD - Rare But Highly Significant: Best Practices in Recognizing and Diagnosing Systemic Mastocytosis


Pushpa Narayanaswami, MD, FAAN - Cutting Through the Congress Cacophony on Generalised Myasthenia Gravis: Expert Honing of the Latest Data
12/12/2024

Pushpa Narayanaswami, MD, FAAN - Cutting Through the Congress Cacophony on Generalised Myasthenia Gravis: Expert Honing of the Latest Data


Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow
11/21/2024

Onyema Ogbuagu, MD, FACP, FIDSA - Multidrug-Resistant HIV: Evaluating HIV Treatment Strategies as Options Narrow


Stephen Jolles, MRCP, FRCPath, PhD - The Many Faces of Primary Immunodeficiencies: Exploring the Plethora of Possibilities Impacting Patient-Integrated Care
11/15/2024

Stephen Jolles, MRCP, FRCPath, PhD - The Many Faces of Primary Immunodeficiencies: Exploring the Plethora of Possibilities Impacting Patient-Integrated Care


Janet Pope, MD, MPH, FRCPC - Understanding the Relevance of Rheumatoid Factor Titers in Rheumatoid Arthritis: From Prognosis to Treatment
10/11/2024

Janet Pope, MD, MPH, FRCPC - Understanding the Relevance of Rheumatoid Factor Titers in Rheumatoid Arthritis: From Prognosis to Treatment


Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey
09/30/2024

Frank Siebenhaar, PD / Vito Sabato, MD, PhD - Optimising Outcomes in Indolent Systemic Mastocytosis: A Comprehensive Review of Best Practices Across the Patient Journey


Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?
08/27/2024

Sharon Walmsley, MD - If the Drugs Are Working, Why Switch HIV Treatment in People Who Are Virologically Suppressed?


Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?
08/23/2024

Jane Anderson, FRCP, PhD - Health-Related Quality of Life: What Works Best for People Living With HIV?


Jan Dutz, MD, FRCPC - Clinical Updates on Targeting IL-17 in Rheumatic Diseases: Striking at the Heart of Inflammatory Processes in PsA and axSpA
08/12/2024

Jan Dutz, MD, FRCPC - Clinical Updates on Targeting IL-17 in Rheumatic Diseases: Striking at the Heart of Inflammatory Processes in PsA and axSpA


Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA
07/10/2024

Xenofon Baraliakos, MD, PhD / Philip Helliwell, MD, PhD - Can the Standard of Care Be Elevated in Spondyloarthropathies? Key Learnings From Rheumacensus Initiatives in PsA and axSpA


Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making
06/25/2024

Milan J. Anadkat, MD - Supporting Patient-Centered Care in Generalized Pustular Psoriasis: Communications Strategies to Improve Shared Decision-Making


Mohamed El-Hussein, RN, PhD, NP / Caitlin Carreau, MN, RN(EC) - At the Forefront of Cancer Prevention: Nursing Strategies to Optimize HPV Immunization
05/30/2024

Mohamed El-Hussein, RN, PhD, NP / Caitlin Carreau, MN, RN(EC) - At the Forefront of Cancer Prevention: Nursing Strategies to Optimize HPV Immunization


Xavier Montalban, MD, PhD - Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
05/30/2024

Xavier Montalban, MD, PhD - Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?


Simon Couillard, MD, MSc - Improving Outcomes in Severe Eosinophilic Asthma: Translating Recent Evidence With Biologics Into Patient Care
03/26/2024

Simon Couillard, MD, MSc - Improving Outcomes in Severe Eosinophilic Asthma: Translating Recent Evidence With Biologics Into Patient Care


George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
02/28/2024

George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action


Martin van Hagen, MD, PhD - Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-Integrated Care
12/01/2023

Martin van Hagen, MD, PhD - Patients Receiving Immunoglobulin Therapy: Emerging Technology for Patient-Integrated Care


Sharon Walmsley, CM, MSc, MD - Individualising ART as We Travel Through Time: Decisions Along a Life’s Journey
11/10/2023

Sharon Walmsley, CM, MSc, MD - Individualising ART as We Travel Through Time: Decisions Along a Life’s Journey


JĂĽrgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH
10/18/2023

JĂĽrgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH


John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Targeting IL-23 in Ulcerative Colitis: Can We Raise the Bar in Disease Control for Our Patients?
10/05/2023

John K. Marshall, MD, MSc, FRCPC, AGAF, CAGF - Targeting IL-23 in Ulcerative Colitis: Can We Raise the Bar in Disease Control for Our Patients?


Antonella Castagna, MD - Designing Treatment Regimens to Suppress Multidrug-Resistant HIV: What Would You Do?
09/20/2023

Antonella Castagna, MD - Designing Treatment Regimens to Suppress Multidrug-Resistant HIV: What Would You Do?


Frank Siebenhaar, MD - Indolent Isn’t Insignificant: Raising Awareness of Systemic Mastocytosis and Its Symptoms
09/14/2023

Frank Siebenhaar, MD - Indolent Isn’t Insignificant: Raising Awareness of Systemic Mastocytosis and Its Symptoms


Irina Turchin, MD, FRCPC, DABD - Unraveling the Pathophysiology of Moderate-to-Severe Atopic Dermatitis: Clinical Implications for Health
09/08/2023

Irina Turchin, MD, FRCPC, DABD - Unraveling the Pathophysiology of Moderate-to-Severe Atopic Dermatitis: Clinical Implications for Health


Sorena Kiani, MBPhD, FRCP, FRCPath - Androgen Risk Reduction in Hereditary Angioedema: Why and How to Switch to Targeted Prophylactic Therapy?
06/19/2023

Sorena Kiani, MBPhD, FRCP, FRCPath - Androgen Risk Reduction in Hereditary Angioedema: Why and How to Switch to Targeted Prophylactic Therapy?


Kurt G. Naber, MD, PhD - How Are We Tackling the Nemesis of Drug-Resistant Uropathogens?
04/27/2023

Kurt G. Naber, MD, PhD - How Are We Tackling the Nemesis of Drug-Resistant Uropathogens?


Michael W. Nicolle, MD, FRCPC, D.Phil - Complement-Directed Therapy for Generalized Myasthenia Gravis: From Bench to Bedside
04/27/2023

Michael W. Nicolle, MD, FRCPC, D.Phil - Complement-Directed Therapy for Generalized Myasthenia Gravis: From Bench to Bedside


Allison Agwu, MD, ScM - Me the Clinician; Me the Mom: Why Vaccinate Children Against COVID-19?
04/24/2023

Allison Agwu, MD, ScM - Me the Clinician; Me the Mom: Why Vaccinate Children Against COVID-19?


Nizar Mahlaoui, MD, MPH, PhD - Simplifying Patient-Integrated Care for Those Requiring Immunoglobulin Therapy: Making Smart Moves with Automated and Digital Technology
04/13/2023

Nizar Mahlaoui, MD, MPH, PhD - Simplifying Patient-Integrated Care for Those Requiring Immunoglobulin Therapy: Making Smart Moves with Automated and Digital Technology


C. Buddy Creech, MD, MPH - Children and the COVID Vaccine
04/11/2023

C. Buddy Creech, MD, MPH - Children and the COVID Vaccine


John Papastergiou, BScPhm, PhDc - Human Papillomavirus Head and Neck Cancers: Improving Outcomes in Adults Through Vaccination
03/28/2023

John Papastergiou, BScPhm, PhDc - Human Papillomavirus Head and Neck Cancers: Improving Outcomes in Adults Through Vaccination


Marina Berenguer, MD, PhD - Treating Hepatitis C Virus in Special Populations: Pregnant Women, Children and Adolescents
03/28/2023

Marina Berenguer, MD, PhD - Treating Hepatitis C Virus in Special Populations: Pregnant Women, Children and Adolescents


Andrew Ustianowski, MBBS, FRCP, PhD - Treating COVID-19 Early: What Patients Need to Know
03/28/2023

Andrew Ustianowski, MBBS, FRCP, PhD - Treating COVID-19 Early: What Patients Need to Know


Anil K. Gupta, MD, CCFP, FCFP - Treating COVID-19 in the Outpatient Setting: Identifying Who, With What, and When?
03/23/2023

Anil K. Gupta, MD, CCFP, FCFP - Treating COVID-19 in the Outpatient Setting: Identifying Who, With What, and When?


Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized Patients
03/23/2023

Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized Patients


Amitava Banerjee, MPH, DPhil, FRCP - Long COVID and Vaccination Status: What Are We Learning?
03/23/2023

Amitava Banerjee, MPH, DPhil, FRCP - Long COVID and Vaccination Status: What Are We Learning?


Andrew Ustianowski, MBBS, FRCP, PhD - What’s Right for Me: Individualising Antiretroviral Therapy in People Living With HIV
03/23/2023

Andrew Ustianowski, MBBS, FRCP, PhD - What’s Right for Me: Individualising Antiretroviral Therapy in People Living With HIV